National Cancer Institute - Slovakia

Site:	National Cancer Institute - Slovakia
Address:
City:	Bratislava
State:	NSW
Zip:
Country:	Slovakia

Phase	Trial	Trial Status	Site Status	Drug [asc]	NCT#
2	A Randomised Trial of Imatinib Alternating With Regorafenib Compared to Imatinib Alone for the First Line Treatment of Advanced Gastrointestinal Stromal Tumour (GIST) (ALT GIST)	Active, not recruiting	Active	Imatinib + Regorafenib	NCT02365441